4.76 USD
↘ 0.24 (4.80%)AT CLOSE (11:59 AM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
4.76
↘ 0.01 (0.11%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
4.76
↘ 0.01 (0.11%)
Market: CLOSED
Seres Therapeutics, Inc. (MCRB) trades at $4.73 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place MCRB at a fair price relative to peers.
Technical & fundamental data as of Aug 26, 2026.
Open?$4.93
High?$5.00
Low?$4.71
Prev. Close?$5.00
Volume?58.2K
Avg. Volume?62.1K
VWAP?$4.81
Rel. Volume?0.94x
Bid / Ask
Bid?$4.12 × 100
Ask?$5.70 × 100
Spread?$1.58
Midpoint?$4.91
Valuation & Ratios
Market Cap?50.2M
Shares Out?10.0M
Float?7.1M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?1.45
EPS?-$2.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
50.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?62
Short Sent.?59
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.61Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?5.21%Elevated
Short Interest?367.9K
Days to Cover?5.4
Free Float7.1M
Avg Daily Volume67.9K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.11Strong
Quick Ratio?2.11Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.45CHEAP▾
Peers100
S&P88
P/S?26.67HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?18.39HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-65.1%WEAK▾
S&P3
ROA?-22.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51295000
Enterprise Value?$34.6M
Fundamentals ratios updated end of day